Fintel reports that on July 14, 2025, BTIG downgraded their outlook for TechnipFMC (NYSE:FTI) from Buy to Neutral. Analyst ...

Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...

Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial (NYSE:SYF) from Neutral to Buy.

I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision ...

As of Monday, the S&P 500 has been trading above its 20-day moving average for 55 days. That's the longest stretch since ...

BTIG downgraded AFRM to "neutral" from "buy" Though shares of buy-now-pay-later name Affirm Holdings Inc (NASDAQ:AFRM) have ...

BTIG upgraded Synchrony Financial (SYF) and Bread Financial (BFH) to Buy, Ally Financial (ALLY) to Neutral and downgraded ...

Billionaire Kerr Neilson has bought over $8 million worth of shares in Flutter Entertainment plc (NYSE:FLUT), representing ...

BTIG to provide strategic advice on capital markets positioning, institutional engagement, and investor outreachAppointment ...

Detailed price information for Tripadvisor Inc (TRIP-Q) from The Globe and Mail including charting and trades.

BTIG made the claim in a lawsuit filed late Monday in California state court and seeks at least $200 million in damages. Have a confidential tip for our reporters? Get in Touch.

Nov 13 (Reuters) - U.S. brokerage firm BTIG on Monday sued rival StoneX Group Inc , opens new tab in San Francisco, accusing it of stealing trade secrets and seeking at least $200 million in damages.